Clinical Trial Update: Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cetuximab plus bevacizumab with 5-FU/leucovorin to oxaliplatin plus bevacizumab with 5-FU/leucovorin in metastatic colorectal cancer. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: US Oncology Research | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-03-14